Tak Wah Mak, Date of Birth, Place of Birth

Tak Wah Mak

Canadian biochemist

Date of Birth: 04-Oct-1946

Place of Birth: Guangzhou, Guangdong, China

Profession: university teacher, biochemist, oncologist

Nationality: Canada

Zodiac Sign: Libra

Tak Wah Mak, (Chinese: ???; pinyin: Mài Déhuá; born October 4, 1946 in China) is a Canadian medical researcher, geneticist, oncologist, and biochemist.
He first became widely known for his discovery of the T-cell receptor in 1983 and pioneering work in the genetics of immunology.
In 1995, Mak published a landmark paper on the discovery of the function of the immune checkpoint protein CTLA-4, thus opening the path for immunotherapy/checkpoint inhibitors as a means of cancer treatment.
Mak is also the founder of Agios Pharmaceuticals, whose lead compound, IDHIFA®, was approved by the FDA for acute myeloid leukemia in August 2017, becoming the first drug specifically targeting cancer metabolism to be used for cancer treatment.
He has worked in a variety of areas including biochemistry, immunology, and cancer genetics.
His groundbreaking work on the T-cell receptor has been postulated to be in consideration for a Nobel Prize.